Open Access Open Access  Restricted Access Subscription or Fee Access

Biomarketing strategy and tactics 101 PART I of III

Dimitris Dogramatzis

Abstract


The American Marketing Association defines marketing as the activity, set of institutions, and processes for creating, communicating, delivering, and exchanging offerings that have value for customers, clients, partners, and society at large.1 According to the Pharmaceutical Research and Manufacturers of America appropriate marketing of medicines ensures that patients have access to the products they need and that the products are used correctly for maximum patient benefit.2 The most important promotional tools for biopharmaceutical firms are 1) personal selling, 2) advertising, 3) public relations and publicity, and 4) web promotion. Part I of this three-part article focuses on the nature of the biopharmaceutical marketing’s four P’s, the importance of marketing strategy, the conduct of environmental analysis,  and maket segmentation. Part II delves into the processes of targeting and positioning, marketing planning, as well as biopharmaceutical branding. Part III completes the series by focusing on the push and pull promotional strategies, advertising, selling, and biopharmaceutical web and social marketing. biopharmaceutical, marketing, targeting, positioning, branding, advertising

Keywords


biopharmaceutical; marketing; targeting; positioning; branding; advertising

Full Text:

PDF

References


American Marketing Association (2011) Marketing definition, www.marketingpower.com/AboutAMA/Pages/DefinitionofMarketing.aspx, accessed 7 October 2011.

Pharmaceutical Research and Manufacturers of America (2008) The facts about pharmaceutical marketing and promotion. Washington, DC: PhRMA.

Borden, N.H. (1965) The concept of the marketing mix. In: G. Schwartz (ed), Science in Marketing. New York, NY: John Wiley & Sons, pp. 386-97.

ACTELION (2011) Annual Report 2010. Allschwil, Switzerland: Actelion, p. 16.

Dogramatzis, D. (2001) Pharmaceutical Marketing: A Practical Guide. Englewood, CO.: IHS Health Group.

AMGEN’s Mission and Values (2011), Thousand Oaks, CA: Amgen, http://www.amgen.com/about/mission_values.html, accessed 1 October 2011.

ABBOTT (2011) Annual Report 2010. Abbott Park, IL: Abbott, p. 62.

Porter, M.E. (1979) How competitive forces shape strategy. Harvard Business Review, 57: 86-93.

AMGEN (2011) Annual Report 2010. Thousand Oaks, CA: Amgen, pp. 19-20.

Freeman, E. (1983) Strategic Management: A Stakeholder Approach. In: R. Lamb (ed.) Latest Advances in Strategic Management, Greenwich: JAI Press, Vol. 1.

ASTRAZENECA (2011) Annual Report 2010. London: AstraZeneca, p. 3.

NOVARTIS (2011) Annual Report 2010. Basel, Switzerland: Novartis, p. 19.

UCB (2011) Annual Report 2010. Brussels, Belgium: UCB, p. 10.

ABBOTT (2011) Annual Report 2010. Abbott Park, IL: Abbott, p. 22.

ROCHE (2011) Annual Report 2010. Basel, Switzerland: Roche, p. 32.

ABBOTT (2011) Annual Report 2010. Abbott Park, IL: Abbott, pp. 13-14.

American Medical Association (AMA) (2009) About AMA. www.ama-assn.org/ama/home/index.shtml, accessed September 2009.

Multiple Sclerosis Society (MS; UK) (2011) What is MS? http://www.mssociety.org.uk/what-is-ms, accessed 3 October 2011.

AMGEN (2011) Annual Report 2010. Thousand Oaks, CA: Amgen, p. 17.

Dogramatzis (2010) Healthcare Biotechnology – A Practical Guide. Boca Raton, FL: CRC Press.

The present article’s figures have been modified form the author’s previously published books, references 5 and 20 above.




DOI: http://dx.doi.org/10.5912/jcb474

Refbacks

  • There are currently no refbacks.




Copyright © thinkBiotech LLC